The Veterinary Therapeutics Market size was valued at USD 49375.13 Million in 2023 and is projected to reach USD 78104.49 Million By 2031 , Growing at CAGR of 5.9% from 2024 to 2031.
The veterinary therapeutics market is poised for significant growth with projections reaching around $39.0 billion and expected to continue this trend during forecast periods.The animal medicine market is experiencing a surge driven by a global rise in pet ownership and increased spending on pet health.
Get More Information on Veterinary Therapeutics Market - Request Sample Report
Rising pet ownership goes hand-in-hand with a growing focus on animal health. This means more pet owners are seeking veterinary care and treatments fueled by government efforts to promote responsible pet ownership and affordable vet care. The veterinary therapeutics market offers a diverse range of medications to treat animal diseases vaccines to prevent illness and even feed additives that promote animal health. This market serves both companion animals and livestock with increasing focus on innovative solutions for each segment. Driven by rising pet ownership and advancements in veterinary medicine the market is poised for significant and lasting growth. The companion animal segment within the veterinary therapeutics market is experiencing a surge in demand for advanced therapies particularly novel vaccines against a wider range of infections. This trend is driving intense competition among veterinary clinics, research institutions and manufacturers. As a result the market is witnessing a flourishing development of cutting-edge treatment options for companion animals.
KEY DRIVERS:
Increase the application of veterinary treatments specifically designed to combat zoonotic diseases.
Zoonotic diseases in pets are on the rise, sparking increased interest in veterinary treatments to combat them and protect both animal and human health. This growing pet population further fuels the veterinary therapeutics market.
The rapidly growing companion animal population worldwide fuels the veterinary therapeutics market due to their increased need for diagnostics and treatment.
RESTRAINTS:
The complex and evolving approval process for veterinary drugs slows down innovation and increases development costs.
Bringing new veterinary drugs to market faces complications as a strict and ever-changing regulations make the approval process lengthy and expensive. Additionally, the use of human drugs in animals (off-label drug use) is a concern as it can have unintended consequences for animal health.
Fewer animals compared to humans means a smaller market for veterinary drugs potentially limiting profits for new developments.
OPPORTUNITIES:
Leveraging advanced technologies to develop more effective vaccines against a wider range of infections.
The demand for cutting-edge therapies in companion animal treatment is skyrocketing compared to the past. Veterinary clinics, hospitals, research institutions and universities are all embracing these advanced treatments to improve pet health outcomes. Driven by high demand veterinary manufacturers are in a heated race to develop the next wave of advanced pet treatments.
This growing desire for cutting-edge veterinary treatments is fueling a dynamic market for innovative medications, therapies and diagnostics
CHALLENGES:
Tough rules for new animal meds slow down progress and make them expensive to develop.
Strict regulations and frequent changes make getting new drugs approved slow and expensive. Additionally using human medications on pets (off-label use) can be risky and relying on human studies for animal drugs isn't ideal. The biggest burden for pet owners is the high cost of veterinary care including medications. To top it off the overuse of antibiotics in animals creates a future threat of antimicrobial resistance.
Stringent and evolving regulations create a costly bottleneck, slowing down the development of new veterinary drugs.
The Impact of Russia Ukraine conflict disrupts the global supply chain potentially impacting India's veterinary drug market even though it mostly focuses on livestock. Since India's animal healthcare industry valued at $950 million is part of the global market price increases and shortages of medications could occur. This is because disruptions can affect all pet and livestock medications not just those for companion animals. Wartime sanctions and economic hardship could restrict access to certain pet medications and force pet owners to skimp on veterinary care.
The impact of economic downturn can crush the veterinary drug market by tighter budgets lead pet owners to cut back on non-essential vet care which reducing demand for medications. They may also become more price-sensitive pressuring clinics to offer discounts that hurt profit margins. Pet owners are placing a growing emphasis on preventative care which is a bright spot for the veterinary drug market. This trend fuels steady demand for specific medications like flea and tick preventatives and heartworm meds even during economic downturns.
By Type
Anti-Inflammatory
Parasiticides
Others
In the absence of specific market share breakdowns industry trends indicate parasiticides as the frontrunner in the veterinary therapeutics market. These medications combat bothersome and potentially harmful pests like fleas, ticks, and worms, a constant concern for pet owners. Anti-inflammatories play a vital role in managing pain and swelling caused by various pet ailments. The "other" category is a broad umbrella encompassing medications for specific illnesses or needs. With parasiticides addressing a prevalent concern this segment likely holds the dominant position in the veterinary therapeutic market.
By Application
Hospitals
Veterinary Clinic
Drug Stores
Others
Veterinary clinics are likely a major distribution channel for veterinary therapeutics. The veterinary therapeutics market is likely driven by veterinary clinics due to their role in administering various treatments. However to pinpoint the dominant segment definitively we would need a clearer picture of the market breakdown by application. This could involve understanding how the market differs based on whether the treatment is administered in a hospital setting (in-patient) or a clinic setting (outpatient).
Need any customization research on Veterinary Therapeutics Market - Enquiry Now
The North America currently holds the dominant position in the veterinary therapeutic market by 45% of market share. North America currently holds the largest market share due to factors like a well-developed healthcare system and high pet ownership. regions like Asia Pacific are expected to see significant growth due to rising pet ownership and livestock populations.
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
The Major Players are Bayer AG., Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Eli Lilly and Company (Elanco Animal Health), Merck Animal Health, Sanofi (Merial Animal Health), Virbac, Vetoquinol S.A., Zoeti and Other Players.
In May 2024: The Future Market Insights Global & Consulting Pvt. Ltd. Spoiled pets and savvy owners are driving the veterinary therapeutic diet market. Expect to see more specialized food options hitting shelves in the US and Japan as these regions lead the pack in growth.
In November 2023: Royal Canin partnered with GekkoVet to bring AI-based veterinary tools to vets in developing countries.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 49375.13 Million |
| Market Size by 2031 | US$ 78104.49 Million |
| CAGR | CAGR of 5.9% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Anti-inflammatory, Parasiticides, Other) • By Application (Hospitals, Veterinary Clinic, Drug Stores, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Bayer AG., Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC,Eli Lilly and Company (Elanco Animal Health), Merck Animal Health, Sanofi (Merial Animal Health), Virbac, Vetoquinol S.A., Zoeti |
Ans: The Veterinary Therapeutics Market is expected to grow at a CAGR of 5.9%.
Ans: Veterinary Therapeutics Market size was USD 49375.13 Million in 2023 and is expected to Reach USD 78104.49 Million by 2031.
The important market trends in the animal therapeutics and diagnostics market include increased demand for animal-free food items and growing concern about zoonotic disease prevention.
Most impact of Ukraine and Russia conflict on the effect of interest and supply, estimating variations, vital take-up of merchants, and suggestions for Veterinary Therapeutics market.
Elanco, Bayer AG, Boehringer Ingelheim GmbH, Zoetis, and Merck are some of the leading veterinary medicine companies.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Industry Flowchart
3. Research Methodology
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
5. Impact Analysis
5.1 Impact Of Russia Ukraine Crisis
5.2 Impact of Economic Slowdown on Major Countries
5.2.1 Introduction
5.2.2 United States
5.2.3 Canada
5.2.4 Germany
5.2.5 France
5.2.6 UK
5.2.7 China
5.2.8 Japan
5.2.9 South Korea
5.2.10 India
6. Value Chain Analysis
7. Porter’s 5 Forces Model
8. Pest Analysis
9. Veterinary Therapeutics Market Segmentation, By Type
9.1 Introduction
9.2 Trend Analysis
9.3 Anti-Inflammatory
9.4 Parasiticides
9.5 Others
10. Veterinary Therapeutics Market Segmentation, By Application
10.1 Introduction
10.2 Trend Analysis
10.3 Hospitals
10.4 Veterinary Clinic
10.5 Drug Stores
10.6 Others
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 Trend Analysis
11.2.2 North America Veterinary Therapeutics Market by Country
11.2.3 North America Veterinary Therapeutics Market By Type
11.2.4 North America Veterinary Therapeutics Market By Application
11.2.5 USA
11.2.5.1 USA Veterinary Therapeutics Market By Type
11.2.5.2 USA Veterinary Therapeutics Market By Application
11.2.6 Canada
11.2.6.1 Canada Veterinary Therapeutics Market By Type
11.2.6.2 Canada Veterinary Therapeutics Market By Application
11.2.7 Mexico
11.2.7.1 Mexico Veterinary Therapeutics Market By Type
11.2.7.2 Mexico Veterinary Therapeutics Market By Application
11.3 Europe
11.3.1 Trend Analysis
11.3.2 Eastern Europe
11.3.2.1 Eastern Europe Veterinary Therapeutics Market by Country
11.3.2.2 Eastern Europe Veterinary Therapeutics Market By Type
11.3.2.3 Eastern Europe Veterinary Therapeutics Market By Application
11.3.2.4 Poland
11.3.2.4.1 Poland Veterinary Therapeutics Market By Type
11.3.2.4.2 Poland Veterinary Therapeutics Market By Application
11.3.2.5 Romania
11.3.2.5.1 Romania Veterinary Therapeutics Market By Type
11.3.2.5.2 Romania Veterinary Therapeutics Market By Application
11.3.2.6 Hungary
11.3.2.6.1 Hungary Veterinary Therapeutics Market By Type
11.3.2.6.2 Hungary Veterinary Therapeutics Market By Application
11.3.2.7 Turkey
11.3.2.7.1 Turkey Veterinary Therapeutics Market By Type
11.3.2.7.2 Turkey Veterinary Therapeutics Market By Application
11.3.2.8 Rest of Eastern Europe
11.3.2.8.1 Rest of Eastern Europe Veterinary Therapeutics Market By Type
11.3.2.8.2 Rest of Eastern Europe Veterinary Therapeutics Market By Application
11.3.3 Western Europe
11.3.3.1 Western Europe Veterinary Therapeutics Market by Country
11.3.3.2 Western Europe Veterinary Therapeutics Market By Type
11.3.3.3 Western Europe Veterinary Therapeutics Market By Application
11.3.3.4 Germany
11.3.3.4.1 Germany Veterinary Therapeutics Market By Type
11.3.3.4.2 Germany Veterinary Therapeutics Market By Application
11.3.3.5 France
11.3.3.5.1 France Veterinary Therapeutics Market By Type
11.3.3.5.2 France Veterinary Therapeutics Market By Application
11.3.3.6 UK
11.3.3.6.1 UK Veterinary Therapeutics Market By Type
11.3.3.6.2 UK Veterinary Therapeutics Market By Application
11.3.3.7 Italy
11.3.3.7.1 Italy Veterinary Therapeutics Market By Type
11.3.3.7.2 Italy Veterinary Therapeutics Market By Application
11.3.3.8 Spain
11.3.3.8.1 Spain Veterinary Therapeutics Market By Type
11.3.3.8.2 Spain Veterinary Therapeutics Market By Application
11.3.3.9 Netherlands
11.3.3.9.1 Netherlands Veterinary Therapeutics Market By Type
11.3.3.9.2 Netherlands Veterinary Therapeutics Market By Application
11.3.3.10 Switzerland
11.3.3.10.1 Switzerland Veterinary Therapeutics Market By Type
11.3.3.10.2 Switzerland Veterinary Therapeutics Market By Application
11.3.3.11 Austria
11.3.3.11.1 Austria Veterinary Therapeutics Market By Type
11.3.3.11.2 Austria Veterinary Therapeutics Market By Application
11.3.3.12 Rest of Western Europe
11.3.3.12.1 Rest of Western Europe Veterinary Therapeutics Market By Type
11.3.2.12.2 Rest of Western Europe Veterinary Therapeutics Market By Application
11.4 Asia-Pacific
11.4.1 Trend Analysis
11.4.2 Asia Pacific Veterinary Therapeutics Market by Country
11.4.3 Asia Pacific Veterinary Therapeutics Market By Type
11.4.4 Asia Pacific Veterinary Therapeutics Market By Application
11.4.5 China
11.4.5.1 China Veterinary Therapeutics Market By Type
11.4.5.2 China Veterinary Therapeutics Market By Application
11.4.6 India
11.4.6.1 India Veterinary Therapeutics Market By Type
11.4.6.2 India Veterinary Therapeutics Market By Application
11.4.7 Japan
11.4.7.1 Japan Veterinary Therapeutics Market By Type
11.4.7.2 Japan Veterinary Therapeutics Market By Application
11.4.8 South Korea
11.4.8.1 South Korea Veterinary Therapeutics Market By Type
11.4.8.2 South Korea Veterinary Therapeutics Market By Application
11.4.9 Vietnam
11.4.9.1 Vietnam Veterinary Therapeutics Market By Type
11.4.9.2 Vietnam Veterinary Therapeutics Market By Application
11.4.10 Singapore
11.4.10.1 Singapore Veterinary Therapeutics Market By Type
11.4.10.2 Singapore Veterinary Therapeutics Market By Application
11.4.11 Australia
11.4.11.1 Australia Veterinary Therapeutics Market By Type
11.4.11.2 Australia Veterinary Therapeutics Market By Application
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Veterinary Therapeutics Market By Type
11.4.12.2 Rest of Asia-Pacific Veterinary Therapeutics Market By Application
11.5 Middle East & Africa
11.5.1 Trend Analysis
11.5.2 Middle East
11.5.2.1 Middle East Veterinary Therapeutics Market by Country
11.5.2.2 Middle East Veterinary Therapeutics Market By Type
11.5.2.3 Middle East Veterinary Therapeutics Market By Application
11.5.2.4 UAE
11.5.2.4.1 UAE Veterinary Therapeutics Market By Type
11.5.2.4.2 UAE Veterinary Therapeutics Market By Application
11.5.2.5 Egypt
11.5.2.5.1 Egypt Veterinary Therapeutics Market By Type
11.5.2.5.2 Egypt Veterinary Therapeutics Market By Application
11.5.2.6 Saudi Arabia
11.5.2.6.1 Saudi Arabia Veterinary Therapeutics Market By Type
11.5.2.6.2 Saudi Arabia Veterinary Therapeutics Market By Application
11.5.2.7 Qatar
11.5.2.7.1 Qatar Veterinary Therapeutics Market By Type
11.5.2.7.2 Qatar Veterinary Therapeutics Market By Application
11.5.2.8 Rest of Middle East
11.5.2.8.1 Rest of Middle East Veterinary Therapeutics Market By Type
11.5.2.8.2 Rest of Middle East Veterinary Therapeutics Market By Application
11.5.3 Africa
11.5.3.1 Africa Veterinary Therapeutics Market by Country
11.5.3.2 Africa Veterinary Therapeutics Market By Type
11.5.3.3 Africa Veterinary Therapeutics Market By Application
11.5.2.4 Nigeria
11.5.2.4.1 Nigeria Veterinary Therapeutics Market By Type
11.5.2.4.2 Nigeria Veterinary Therapeutics Market By Application
11.5.2.5 South Africa
11.5.2.5.1 South Africa Veterinary Therapeutics Market By Type
11.5.2.5.2 South Africa Veterinary Therapeutics Market By Application
11.5.2.6 Rest of Africa
11.5.2.6.1 Rest of Africa Veterinary Therapeutics Market By Type
11.5.2.6.2 Rest of Africa Veterinary Therapeutics Market By Application
11.6 Latin America
11.6.1 Trend Analysis
11.6.2 Latin America Veterinary Therapeutics Market by Country
11.6.3 Latin America Veterinary Therapeutics Market By Type
11.6.4 Latin America Veterinary Therapeutics Market By Application
11.6.5 Brazil
11.6.5.1 Brazil Veterinary Therapeutics Market By Type
11.6.5.2 Brazil Veterinary Therapeutics Market By Application
11.6.6 Argentina
11.6.6.1 Argentina Veterinary Therapeutics Market By Type
11.6.6.2 Argentina Veterinary Therapeutics Market By Application
11.6.7 Colombia
11.6.7.1 Colombia Veterinary Therapeutics Market By Type
11.6.7.2 Colombia Veterinary Therapeutics Market By Application
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Veterinary Therapeutics Market By Type
11.6.8.2 Rest of Latin America Veterinary Therapeutics Market By Application
12. Company Profiles
12.1 Bayer AG
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Boehringer Ingelheim GmbH
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Ceva Sante Animale
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.3.5 The SNS View
12..4 Dechra Pharmaceuticals PLC
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Eli Lilly and Company (Elanco Animal Health)
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Merck Animal Health
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Sanofi (Merial Animal Health)
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Virbac
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Vetoquinol S.A.
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Zoeti
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. USE Cases And Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Anti-Fungal Treatment Market Size was valued at USD 16.83 billion in 2023, and is expected to reach USD 22.82 billion by 2031 and grow at a CAGR of 3.88% over the forecast period 2024-2031.
The Point of Care Diagnostics/Testing Market Size was valued at USD 44.5 billion in 2023 and is expected to reach USD 70.92 billion by 2031 and grow at a CAGR of 6% over the forecast period 2024-2031.
The Electronic Medical Record (EMR) Systems Market size was valued at US$ 29.05 billion in 2023 and is projected to reach over US$ 40.37 billion by 2031, with a growing CAGR of 4.2% during the forecast period 2024-2031.
The Pharmacovigilance and Drug Safety Software Market Size was valued at USD 6.83 billion in 2022, and is expected to reach USD 14.86 billion by 2030, and grow at a CAGR of 10.2% over the forecast period 2023-2030.
The Cystic Fibrosis Market size was valued at US$ 6.02 Billion in 2023 and is estimated to reach US$ 18.66 Billion by 2032 with a growing CAGR of 13.4% Over the Forecast Period 2024-2032.
The DNA Synthesis Market size was estimated at USD 3.08 billion in 2023 and is expected to reach USD 11.22 billion by 2032 with a growing CAGR of 15.45% during the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
